Cultivated meat has won regulatory approval in the United States and Singapore. Understanding the regulatory pathway matters for how quickly this technology can reach scale and reduce animal use.
If cultivated meat reaches cost parity and scale, it could dramatically reduce the number of animals slaughtered for food. The regulatory trajectory is therefore directly linked to animal welfare outcomes at scale. Key bottlenecks include cell line sourcing (some still use foetal bovine serum), food safety review timelines, and political opposition from incumbent industries. Consumer acceptance and clear, honest labelling are also critical for adoption.